Your browser doesn't support javascript.
loading
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation.
Xuan, Li; Wang, Yu; Chen, Jia; Jiang, Erlie; Gao, Li; Wu, Bingyi; Deng, Lan; Liang, Xinquan; Huang, Fen; Fan, Zhiping; Tang, Xiaowen; Sun, Jing; Zhang, Xi; Han, Mingzhe; Wu, Depei; Huang, Xiaojun; Liu, Qifa.
Affiliation
  • Xuan L; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Y; Institute of Hematology, Peking University People's Hospital, Beijing, China.
  • Chen J; The first affiliated hospital of Soochow University, Suzhou, China.
  • Jiang E; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, China.
  • Gao L; Department of Hematology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
  • Wu B; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Deng L; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Liang X; Department of Hematology, First People's Hospital of Chenzhou, Southern Medical University, Chenzhou, China.
  • Huang F; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Fan Z; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Tang X; The first affiliated hospital of Soochow University, Suzhou, China.
  • Sun J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang X; Department of Hematology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
  • Han M; Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Tianjin, China.
  • Wu D; The first affiliated hospital of Soochow University, Suzhou, China.
  • Huang X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Institute of Hematology, Peking University People's Hospital, Beijing, China.
  • Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Guangzhou, China. Electronic address: liuqifa628@163.com.
Biol Blood Marrow Transplant ; 25(8): 1674-1681, 2019 08.
Article in En | MEDLINE | ID: mdl-31009704
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Leukemia, Myeloid, Acute / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Tandem Repeat Sequences / Fms-Like Tyrosine Kinase 3 / Sorafenib Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Biol Blood Marrow Transplant Year: 2019 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Leukemia, Myeloid, Acute / Salvage Therapy / Hematopoietic Stem Cell Transplantation / Tandem Repeat Sequences / Fms-Like Tyrosine Kinase 3 / Sorafenib Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Biol Blood Marrow Transplant Year: 2019 Type: Article Affiliation country: China